Thymoquinone potentiates anti‐cancer effects of cisplatin in oral squamous cell carcinoma via targeting oxidative stress
Chemical Biology & Drug Design · 2024
DOI: 10.1111/cbdd.14492 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Mohsen Karami Fath und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Head and Neck Neoplasms, Benzoquinones. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Recent evidence has proved that thymoquinone as a natural polyphenol has great anticancer and anti‐proliferative effects in cancer cells. In this study, we aimed to examine the effects of thymoquinone on increasing cisplatin‐induced apoptosis human oral squamous cell carcinoma cells and its underlying molecular mechanisms. SCC‐25 cancer cells treated by thymoquinone and cisplatin with different concentrations. Cell viability will determine by using MTT assay. The concentrations of reactive oxygen species (ROS) and antioxidant activities were determined using specific related kits. DNA damage, lipid, and protein oxidation were assessed. Real‐time PCR and Western blot analysis will be used to determine the expression of apoptosis‐related proteins including Bax, Bcl‐2, and caspase‐3. Combination of thymoquinone and cisplatin suppressed synergistically SCC‐25 cancer cell viability and induced apoptosis in dose‐depended manner. Cell treatment with combination of thymoquinone and cisplatin led to accumulation of ROS within cells and increase in the intracellular levels of DNA damage, protein and lipid peroxidation. In addition, the combination of thymoquinone and cisplatin modulated the mRNA and protein expression levels of apoptosis‐related proteins including Bax, Bcl‐2, and caspase‐3. Thymoquinone potentiated cisplatin anti‐cancer effect on OSCC by inducing oxidative stress in cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cellular and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
- Faculty of Dentistry, Islamic Azad University of Medical Sciences, Tehran, Iran.
- Faculty of Dentistry, Qazvin University of Medical Sciences, Qazvin, Iran.
- School of Dentistry, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
- Faculty of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
- Faculty of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Fath, M. K., Nasiri, K., Ghasemzadeh, S., Nejati, S. T., Ghafari, N., Masouleh, S. S., Dadgar, E., Kazemi, K. S., & Esfahaniani, M. (2024). Thymoquinone potentiates anti‐cancer effects of cisplatin in oral squamous cell carcinoma via targeting oxidative stress. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14492
Vancouver
Fath MK, Nasiri K, Ghasemzadeh S, Nejati ST, Ghafari N, Masouleh SS, et al. Thymoquinone potentiates anti‐cancer effects of cisplatin in oral squamous cell carcinoma via targeting oxidative stress. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14492
BibTeX
@article{Fath2024,
author = {Fath, Mohsen Karami and Nasiri, Kamyar and Ghasemzadeh, Shabnam and Nejati, Seyedeh Tabasom and Ghafari, Nima and Masouleh, Sahand Saeidpour and Dadgar, Esmaeel and Kazemi, Kimia Sadat and Esfahaniani, Mahla},
title = {Thymoquinone potentiates anti‐cancer effects of cisplatin in oral squamous cell carcinoma via targeting oxidative stress},
journal = {Chemical Biology & Drug Design},
year = {2024},
doi = {10.1111/cbdd.14492}
}
EUVIMED